|

Nadunolimab Clinical Trials

2 actively recruiting trials across 2 locations

New York, New York1 trial

Combination Immunotherapy for the Treatment of Chemotherapy-refractory Metastatic MSS CRC

Icahn School of Medicine at Mount Sinai

Phase 1/2

Houston, Texas1 trial

A Phase 1B/2A Trial of NADUNOLIMAB in Combination With Azacitidine (With/Without Venetoclax) in Patients With Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)

MD Anderson Cancer Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.